Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer

PURPOSE: Therapeutic prostate-specific antigen (PSA) –targeted poxviral vaccines for prostate cancer have been well tolerated. PROSTVAC-VF treatment was evaluated for safety and for prolongation of progression-free survival (PFS) and overall survival (OS) in a randomized, controlled, and blinded pha...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Kantoff, Philip W., Schuetz, Thomas J., Blumenstein, Brent A., Glode, L. Michael, Bilhartz, David L., Wyand, Michael, Manson, Kelledy, Panicali, Dennis L., Laus, Reiner, Schlom, Jeffrey, Dahut, William L., Arlen, Philip M., Gulley, James L., Godfrey, Wayne R.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Clinical Oncology 2010
Gaiak:
Original Reports
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2834462/
https://ncbi.nlm.nih.gov/pubmed/20100959
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.25.0597
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak